Aldeyra Therapeu (ALDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,149 | 14,649 | 30,618 | 33,570 | 15,721 |
| Marketable Securities | 12,877 | 12,942 | N/A | N/A | N/A |
| TOTAL | $23,309 | $28,088 | $31,226 | $33,837 | $15,898 |
| Non-Current Assets | |||||
| PPE Net | 82 | 80 | 89 | 41 | 13 |
| Other Non-Current Assets | 46 | 36 | 36 | 0 | 20 |
| TOTAL | $128 | $117 | $125 | $41 | $33 |
| Total Assets | $23,437 | $28,205 | $31,350 | $33,878 | $15,931 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 194 | 78 | N/A | 310 | 194 |
| Accounts payable and accrued liabilities | 578 | 851 | 744 | 629 | 406 |
| Accrued Expenses | 1,036 | 1,186 | 630 | 452 | 436 |
| TOTAL | $1,808 | $2,115 | $1,374 | $1,391 | $1,036 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,102 | 1,211 | 1,281 | 962 | 1,069 |
| TOTAL | $1,102 | $1,211 | $1,281 | $962 | $1,069 |
| Total Liabilities | $2,910 | $3,326 | $2,655 | $2,353 | $2,105 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,713 | 9,713 | 9,713 | 9,713 | 9,590 |
| Common Shares | 10 | 10 | 10 | 10 | 7 |
| Retained earnings | -63,569 | -58,602 | -54,246 | -50,880 | -48,648 |
| Other shareholders' equity | 2 | -8 | 0 | 0 | 0 |
| TOTAL | $20,527 | $24,878 | $28,695 | $31,525 | $13,827 |
| Total Liabilities And Equity | $23,437 | $28,205 | $31,350 | $33,878 | $15,931 |